Skip to main content
Premium Trial:

Request an Annual Quote

Abbott Q2 MDx Sales Inch up 1 Percent

NEW YORK (GenomeWeb News) – Abbott today reported its molecular diagnostics business rose 1 percent year over year during the second quarter while total sales grew 2 percent.

For the three months ended June 30, molecular diagnostics sales increased to $106 million, compared to $105 million a year ago. In the US, molecular diagnostics rose 7.3 percent year over year to $48 million, while internationally, the business dropped 3.8 percent to $58 million.

Abbott repeated expectations of 15 new molecular diagnostic product launches during the next few years, including assays for oncology, infectious diseases, and companion diagnostics.

In total, sales for the second quarter increased to $9.81 billion, compared to $9.62 billion a year ago. Net earnings for the quarter fell to $1.73 billion, or $1.08 per share, from $1.94 billion, or $1.23 per share, a year ago.

Abbott reiterated full-year 2012 EPS guidance of between $5 and $5.10.

The company reported last year that it is splitting its business into two publicly traded firms, one concentrated on research-based pharmaceuticals and the other on diversified medical products, including its diagnostics businesses. Abbott said today that it continues to expect the separation to be completed at the end of the year.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.